Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. Summary
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
44.2(c) 43.92(c) 43.95(c) 44.19(c) 43.94(c) Last
41 873 015 23 645 594 22 616 743 19 719 166 16 150 746 Volume
+0.71% -0.63% +0.07% +0.55% -0.57% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 81 115 M - -
Net income 2021 18 438 M - -
Net Debt 2021 28 980 M - -
P/E ratio 2021 13,0x
Yield 2021 3,59%
Sales 2022 67 785 M - -
Net income 2022 16 472 M - -
Net Debt 2022 22 870 M - -
P/E ratio 2022 14,1x
Yield 2022 3,73%
Capitalization 246 B 246 B -
EV / Sales 2021 3,39x
EV / Sales 2022 3,97x
Nbr of Employees 78 500
Free-Float 59,3%
More Financials
Company
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines... 
Read more
Sector
Pharmaceuticals
Calendar
09/27 | 12:10pmPresentation
More about the company
Ratings of Pfizer, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about PFIZER, INC.
02:40aASTRAZENECA : Pfizer Deny Spat Following Lawyer's Leaked Health Threat Accusation
MT
01:21aASTRAZENECA : Pfizer's comments on rival vaccine posed 'health threat'
AQ
01:00aGlobal vaccines project to revamp rules after Britain got more than Botswana
RE
09/26MODERNA : U.S. administers 390.1 mln doses of COVID-19 vaccines - CDC
RE
09/26THE LATEST : CDC head acknowledges confusion over boosters
AQ
09/26New York may tap National Guard to replace unvaccinated healthcare workers
RE
09/26PFIZER : US has enough COVID-19 vaccines for boosters, kids shots
AQ
09/25PFIZER : Israel says US booster plan supports its own aggressive push
AQ
09/25AP NEWS IN BRIEF AT 12 : 04 a.m. EDT
AQ
09/24PFIZER : Guest lineups for the Sunday news shows
AQ
09/24ADRs End Lower; WPP, BioNTech Among Companies Actively Trading
DJ
09/24SCHOOL DISRUPTION, 'LONG COVID,' ALL : Tam
AQ
09/24PFIZER : OPKO Health Get FDA Extension for Review of Somatrogon Biologics License Applicat..
MT
09/24Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application ..
CI
09/24PFIZER : Residents of Saugeen First Nation given expired COVID-19 Pfizer vaccine for weeks
AQ
More news
News in other languages on PFIZER, INC.
02:40aAstraZeneca et Pfizer démentent leur différend suite à la fuite d'une accusation de men..
09/26CORONAVIRUS : le point sur la pandémie dans le monde
09/24COVID : boost d'anticorps avec une 3e dose Pfizer, après deux doses de Coronavac
09/24La campagne de rappel de vaccin anti-Covid lancée aux Etats-Unis
09/24Walmart et Sam's Club administreront des injections de rappel de COVID-19 de Pfizer
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Analysis
Viatris : Former Mylan executive pleads guilty to insider trading
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 43,94 $
Average target price 45,19 $
Spread / Average Target 2,84%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.19.37%246 358
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037
ABBVIE INC.-0.07%189 211